Xiquan Liu

Title: Xiquan Liu: Innovator in Transdermal Drug Delivery Systems

Introduction

Xiquan Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal drug delivery systems. His innovative work has led to the creation of a unique composition that enhances the effectiveness of Rotigotine, a medication used for treating Parkinson's disease.

Latest Patents

Xiquan Liu holds a patent for a transdermal patch containing Rotigotine. This patent describes a Rotigotine-containing composition that features a matrix mixture system formed from polyvinylpyrrolidone and a combination of acrylic and silicone pressure-sensitive adhesives. The formulation includes 1-40% of Rotigotine based on the total weight of the composition. The innovative composition provides improved solubility, release, and initial penetration levels of Rotigotine, making it a valuable advancement in transdermal drug delivery.

Career Highlights

Xiquan Liu is associated with Jiangsu Kangbeide Pharmaceuticals Co. Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation and delivery systems has positioned him as a key figure in the industry. Liu's dedication to research and development has resulted in advancements that benefit patients and healthcare providers alike.

Collaborations

Xiquan Liu collaborates with notable colleagues such as Shuming Wang and Huiyong Xue. Their combined efforts contribute to the ongoing research and development of effective pharmaceutical products.

Conclusion

Xiquan Liu's contributions to the field of pharmaceuticals, particularly through his innovative transdermal patch for Rotigotine, highlight his role as a leading inventor. His work not only advances drug delivery systems but also improves patient outcomes in the treatment of Parkinson's disease.